Purpose/Objectives: Cardiovascular disease (CVD) is the most common non-cancer cause of death among long-term survivors of pediatric cancer. We examined radiotherapy (RT) volumetric dose data to improve our understanding of RT-associated CVD risk in long-term survivors of childhood cancer.
Results: At a median age of 28.4 years (range, 5.6 -58.3) and time from diagnosis of 20.2 years (range, 5.0 -39.3), 239 CAD and 359 HF events occurred. The cumulative incidence estimates of CVD, CAD, and HF were 4.8% (95% CI 4.3-5.3), 2.4% (95% CI 2.2-2.9), and 2.5% (95% CI 2.2-2.9), respectively, at 30 years from diagnosis. As shown in the table below, at a V20 of 0.1 -<25%, the risk for CVD was increased, primarily due to HF. The risk of CVD was greatest in those with a V20 of ≥50%, and not associated with age at diagnosis. To separately consider patients who received low-dose cardiac RT, we examined V5 in patients with a V20 of 0%. Those with a V5 of 50% and a V20 of 0% had an increased risk of CVD (RR, 1.7; 95% CI, 1.2 -2.4; p = 0.004) compared to those with a V5 of 0%. The risk in this subset of patients was also not associated with age at diagnosis. Increased risk was not seen with lower V5 percentages.
Conclusions:
Cardiac RT dose of 20 Gy or more, even to a low volume, substantially increased the risk for CVD, with further increased risk at V20 ≥50%. Additionally, survivors who received large-volume, lowdose cardiac RT (V5  50% and V20 = 0%) had an increased risk for CVD. Age at diagnosis did not significantly impact the risk for CVD in this volumetric analysis. These results should guide future surveillance and treatment protocols. 
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